Actavis Reaches Exalgo Settlement With Mallinckrodt

Drug Industry Daily
A A
Actavis and Mallinckrodt have reached a settlement on litigation over a 32-mg generic version of Mallinckrodt’s painkiller Exalgo.

To View This Article:

Login

Subscribe To Drug Industry Daily